Artelo Biosciences Inc. (ARTL)
undefined
undefined%
At close: undefined
1.11
0.00%
After-hours Dec 13, 2024, 06:21 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -10.08M -7.44M -4.65M -2.17M -2.34M -234.89K -29.69K -15.24K -15.27K
Depreciation & Amortization - - 500.00 510.00 282.00 600.00 - - -
Stock-Based Compensation 2.46M 1.53M 377.77K 425.11K 290.00K 3.33K - - -
Other Working Capital -195.00K -239.00K -169.26K 40.39K -57.51K -1.50K - - -
Other Non-Cash Items -211.00K 7.00K -29.50K 100.00K - 600.00 - - -14.73K
Deferred Income Tax - - - -1.01M - -600 - - -
Change in Working Capital -172.00K -242.00K -41.28K -140.02K 443.19K 14.14K 11.20K 1.74K 14.73K
Operating Cash Flow -8.01M -6.14M -4.35M -2.79M -1.61M -216.82K -18.49K -13.50K -15.27K
Capital Expenditures - - - -1.50M -845 - - - -
Acquisitions - - - - - - - - -
Purchase of Investments -13.22M -3.44M - - - - - - -
Sales Maturities Of Investments 16.18M - - - - - - - -
Other Investing Acitivies - - - - - - - - -
Investing Cash Flow 2.96M -3.44M - -1.50M -845 - - - -
Debt Repayment - - - - - - - - -
Common Stock Repurchased - - -108 - - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies - 6.01M 3.15K 1.05K 1.84K 42.67K 5.05K - -
Financial Cash Flow - 14.11M 1.98M 8.38M 1.39M 785.35K 5.05K 15.80K 30.00K
Net Cash Flow -5.27M 4.49M -2.28M 4.09M -235.35K 569.18K -13.44K 2.30K 14.73K
Free Cash Flow -8.01M -6.14M -4.35M -4.29M -1.61M -216.82K -18.49K -13.50K -15.27K